Resolving discordant CYP2D6 genotyping results in Thai: platform limitations and novel haplotypes

被引:10
作者
Hongkaew, Yaowaluck [1 ]
Wang, Wendy Y. [2 ]
Gaedigk, Roger [2 ]
Sukasem, Chonlaphat [3 ]
Gaedigk, Andrea [2 ,4 ]
机构
[1] Bumrungrad Int Hosp, Div Adv Res & Dev Lab, Dept Lab, Bangkok, Thailand
[2] Childrens Mercy Kansas City, Div Clin Pharmacol Toxicol & Therapeut Innovat, Kansas City, MO 64108 USA
[3] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pathol,Div Pharmacogen & Personalized Med, Bangkok 10400, Thailand
[4] Univ Missouri, Sch Med, Kansas City, MO 64108 USA
关键词
genotype; Luminex xTAG; risperidone; Thai; POLYMORPHISM; RISPERIDONE; ASSOCIATION; 9-HYDROXYRISPERIDONE; PHARMACOGENETICS; IDENTIFICATION; POPULATION; CHILDREN; GENES;
D O I
10.2217/pgs-2021-0013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim: Several CYP2D6 Luminex xTAG genotype calls were identified as inconsistent or suspicious among Thai subjects and further characterized to identify the root causes. Material & methods: Forty-eight subjects were followed-up with long-range-PCR, quantitative copy number assays and/or Sanger sequencing. Results: Most of the Luminex-duplication calls were either negative or had hybrid structures involving CYP2D6*36 in various configurations. Ten samples were inaccurately called as CYP2D6*2, *29 or *35 alleles. Sequencing revealed three novel haplotypes, CYP2D6*142, *143 and *144 of which two are nonfunctional. Conclusion: The Luminex platform produced a relatively high number of false genotype calls for Thai subjects. Our findings underscore the need for the systematic characterization of the CYP2D6 locus in diverse populations and rigorous platform validation.
引用
收藏
页码:529 / 541
页数:13
相关论文
共 37 条
[1]   Endoxifen Levels and Its Association With CYP2D6 Genotype and Phenotype: Evaluation of a Southern Brazilian Population Under Tamoxifen Pharmacotherapy [J].
Antunes, Marina V. ;
Linden, Rafael ;
Santos, Tamyris V. ;
Wallemacq, Pierre ;
Haufroid, Vincent ;
Classen, Jean-Francois ;
Andreolla, Huander ;
Costa, Nathalia ;
Fontanive, Tiago O. ;
Rosa, Daniela D. .
THERAPEUTIC DRUG MONITORING, 2012, 34 (04) :422-431
[2]  
Bathum L, 1998, PHARMACOGENETICS, V8, P119
[3]   Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence-based genetic testing panel [J].
Bousman, Chad ;
Al Maruf, Abdullah ;
Mueller, Daniel J. .
CURRENT OPINION IN PSYCHIATRY, 2019, 32 (01) :7-15
[4]   Navigating the Labyrinth of Pharmacogenetic Testing: A Guide to Test Selection [J].
Bousman, Chad A. ;
Zierhut, Heather ;
Muller, Daniel J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (02) :309-312
[5]   Systematic evaluation of commercial pharmacogenetic testing in psychiatry: a focus on CYP2D6 and CYP2C19 allele coverage and results reporting [J].
Bousman, Chad A. ;
Jaksa, Philip ;
Pantelis, Christos .
PHARMACOGENETICS AND GENOMICS, 2017, 27 (11) :387-393
[6]   Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group [J].
Caudle, Kelly E. ;
Sangkuhl, Katrin ;
Whirl-Carrillo, Michelle ;
Swen, Jesse J. ;
Haidar, Cyrine E. ;
Klein, Teri E. ;
Gammal, Roseann S. ;
Relling, Mary, V ;
Scott, Stuart A. ;
Hertz, Daniel L. ;
Guchelaar, Henk-Jan ;
Gaedigk, Andrea .
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (01) :116-124
[7]   CYP2D6 genotype analysis of a Thai population: platform comparison [J].
Chamnanphon, Monpat ;
Gaedigk, Andrea ;
Vanwong, Natchaya ;
Nuntamool, Nopphadol ;
Hongkaew, Yaowaluck ;
Puangpetch, Apichaya ;
Sukasem, Chonlaphat .
PHARMACOGENOMICS, 2018, 19 (12) :947-960
[8]   Association of CYP2D6 and CYP2C19 polymorphisms and disease-free survival of Thai post-menopausal breast cancer patients who received adjuvant tamoxifen [J].
Chamnanphon, Montri ;
Pechatanan, Khunthong ;
Sirachainan, Ekapob ;
Trachu, Narumol ;
Chantratita, Wasun ;
Pasomsub, Ekawat ;
Noonpakdee, Wilai ;
Sensorn, Insee ;
Sukasem, Chonlaphat .
PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2013, 6 :37-48
[9]   CYP2D6 genotype can help to predict effectiveness and safety during opioid treatment for chronic low back pain: results from a retrospective study in an Italian cohort [J].
Dagostino, Concetta ;
Allegri, Massimo ;
Napolioni, Valerio ;
D'Agnelli, Simona ;
Bignami, Elena ;
Mutti, Antonio ;
van Schaik, Ron H. N. .
PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2018, 11 :179-191
[10]   Development of Customizable Implementation Guides to Support Clinical Adoption of Pharmacogenomics: Experiences of the Implementing GeNomics In pracTicE (IGNITE) Network [J].
Duong, Benjamin Q. ;
Arwood, Meghan J. ;
Hicks, J. Kevin ;
Beitelshees, Amber L. ;
Franchi, Francesco ;
Houder, John T. ;
Limdi, Nita A. ;
Cook, Kelsey J. ;
Obeng, Aniwaa Owusu ;
Petry, Natasha ;
Tuteja, Sony ;
Elsey, Amanda R. ;
Cavallari, Larisa H. ;
Wiisanen, Kristin .
PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2020, 13 :217-226